The Valley Desk

NCT05498272 · Interventional trial

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Overall registry status Active not recruiting

Phase 2

Conditions BRCA1 Mutation, BRCA2 Mutation, High-Risk Cancer, Prostate Cancer, Prostatic Adenocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov